胃癌:从生物标志物到功能精密医学
Philipp Albrecht1, Ekin Karabati2, Matthias P Ebert3
1Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Medicine II, Mannheim Medical Faculty, Heidelberg University, Mannheim, Germany; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany; DKFZ Hector Cancer Institute at University Medical Center Mannheim, Mannheim, Germany.
胃癌治疗正在随着新的向疗法和精准医学方法的发展而发展. 分子诊断和患者衍生模型的进步旨在改善晚期胃癌患者的生存率.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 胃癌 (GC) 由于晚期检测和有限的先进阶段治疗选择,造成了显著的死亡率挑战.
- 目前转移性GC的治疗方法包括化疗和向抗体 (HER2,VEGFR2,PD-1,克劳丁18.2).
研究的目的:
- 对胃癌的新兴治疗点和新药类进行审查.
- 讨论精准医学和先进诊断在改善GC治疗策略中的作用.
主要方法:
- 审查关于胃癌治疗的当前文献.
- 对正在进行的精准医学试验和分子诊断整合的分析.
主要成果:
- 像FGFR2b这样的新兴标和新药类,如抗体-药物合物 (ADC) 和双特异性抗体,显示出有前途.
- 精准医学试验和分子瘤板正在促进GC疗法的快速发展.
结论:
- 尽管有挫折,但GC治疗领域正在迅速发展,新的向性药物和个性化的方法正在迅速发展.
- 整合omics数据和功能性药物测试具有个性化瘤学和改善患者生存的潜力.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
相关概念视频
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Serum Laboratory Studies, Stool Test, Breath Test